Pharsight

Beyaz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US6441168 BAYER HLTHCARE Stable crystalline salts of 5-methyltetrahydrofolic acid
Jul, 2022

(1 year, 7 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7163931 BAYER HLTHCARE Compositions of estrogen-cyclodextrin complexes
Mar, 2022

(2 years ago)

US8617597 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Feb, 2030

(5 years from now)

US11617751 BAYER HLTHCARE Pharmaceutical composition containing a tetrahydrofolic acid
Jul, 2030

(6 years from now)

Beyaz is owned by Bayer Hlthcare.

Beyaz contains Drospirenone; Ethinyl Estradiol; Levomefolate Calcium.

Beyaz has a total of 4 drug patents out of which 2 drug patents have expired.

Expired drug patents of Beyaz are:

  • US7163931
  • US6441168

Beyaz was authorised for market use on 24 September, 2010.

Beyaz is available in tablet;oral dosage forms.

Beyaz can be used as prevention of pregnancy, prevention of pregnancy; raise folate levels in women who choose to use an oral contraceptive as their method of contraception for the purpose of reducing the risk of a neural tube defect in a pregnancy; treatment of moderate acne vulgaris in women at least 14 years of age if the patient desires an oral contraceptive for birth control; treatment of mood changes and/or anxiety as symptoms of premenstrual dysphoric disorder (pmdd) in women who choose to use an oral contraceptive as their method of contraception.

The generics of Beyaz are possible to be released after 17 July, 2030.

Drugs and Companies using DROSPIRENONE; ETHINYL ESTRADIOL; LEVOMEFOLATE CALCIUM ingredient

Market Authorisation Date: 24 September, 2010

Treatment: Prevention of pregnancy; Raise folate levels in women who choose to use an oral contraceptive as their method of contraception for the purpose of reducing the risk of a neural tube defect in a pregnan...

Dosage: TABLET;ORAL

How can I launch a generic of BEYAZ before it's drug patent expiration?
More Information on Dosage

BEYAZ family patents

Family Patents